Biologic Advancements for Psoraisis

Biologic agents over the past 15 years have offered new freedom to people living with psoriasis. These protein molecules administered under the skin decrease the inflammatory response that is created in the skin and cause psoriasis.

Written by Dr. Jerry Bagel

Two treatments in particular Humira and Stelara can improve an individual's psoriasis by75%, 75% of the time.  Furthermore it can improve psoriasis 90%.  Half of the time Humira is administered every other week at home by the patient, whereas Stelara is administered every 12 weeks in the office. 

The most common risk associated with the administration of biologic agents is a 1-2 % increase in infections requiring antibiotic therapy.  Although there has been fear that biologic agents increase the frequency of cancer, both short and long term safety data do not reveal an increase in cancer when biologic agents are used.  

If you are interested in learning more about biologic agents, how they work and what type might be best for you call our office at 609-443-4500.

Psoriasis Success Stories

It's Psoriasis Awareness Month, so we'd like to share with you a few recent Windsor Dermatology success stories...

Bowler Gets Back to the Lanes

Recently a 47 year old male with psoriasis on 40% of body complained of hand stiffness and finger swelling secondary to psoriatic arthritis. He was depressed, stayed home, had difficulty working and couldn’t bowl anymore due to swollen fingers.

He was treated in a clinical trial with amazing results. His psoriasis cleared completely, his fingers improved and he could go work—and bowl again!

Jerry Bagel, M.D.

From Painful Psoriasis to Enjoyable Summer

One patient presented in our office suffering with over 20% of his body covered in painful psoriasis. He was treated three times a week with light treatments in combination with Humira. Within three months, he only has a small plaque on his lower back. The patient is so thankful to have regained his quality of life—pain free! He has since discontinued light treatments and is enjoying his summer. The patient is extremely happy, along with the physician and nurses.

Crystal Snyder, LPN

Research Trial Helps Fight Psoriatic Arthritis

A patient presented in our office with debilitating psoriatic arthritis. He had difficulty holding a pen and writing. Within four weeks of being on a Humira research trial, the patient was able to resume his normal daily living functions. He is extremely happy for the difference we made in his life.

Elise Nelson, Clinical Trials Coordinator

Patient Has New Outlook On Life

A 20 year old patient came in to our office with no insurance. She had severe plaque psoriasis covering 80% of her body surface. She was a definite candidate for the Enbrel clinical trial. Within 12 weeks, her psoriasis became 75% better. She has a new outlook on life.

Elise Nelson, Clinical Trials Coordinator